The key support level of Jubilant Life Sciences is Rs 875 and that’s where its 20-day moving average is and the uptrend that is seen is backed by volumes. Its 10-day average volumes are 55 percent higher as compared to 3-month volume and similarly its delivery volumes also higher by 65 percent as compared to its 3-month average volumes.
The reason behind these gains is that it has already commenced operations and manufacturing when it comes to the COVID vaccines at Spokane and Montreal plant.
JM Financials also expects a significant recovery in some of its other sectors and that’s the reason why gains are seen in Jubilant Life Sciences.
Watch the video for more